Nanotechnology application for pain therapy

Prolonged delivery of analgesic drugs at target sites remains a critical issue for efficient pain management. The use of nano-carriers has been reported to facilitate applicable delivery of these agents to target sites with a reduced level of systemic toxicity. Different analgesics have been loaded...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Artificial cells, nanomedicine, and biotechnology nanomedicine, and biotechnology, 2018-03, Vol.46 (2), p.368-373
Hauptverfasser: Moradkhani, Mahmoud Reza, Karimi, Arash, Negahdari, Babak
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 373
container_issue 2
container_start_page 368
container_title Artificial cells, nanomedicine, and biotechnology
container_volume 46
creator Moradkhani, Mahmoud Reza
Karimi, Arash
Negahdari, Babak
description Prolonged delivery of analgesic drugs at target sites remains a critical issue for efficient pain management. The use of nano-carriers has been reported to facilitate applicable delivery of these agents to target sites with a reduced level of systemic toxicity. Different analgesics have been loaded onto various nano carriers, including those that are natural, synthetic and copolymer, for various medical applications. In this review, we will discuss the concept of nano-formulated carriers for analgesic drugs and their impacts on the field of pain management.
doi_str_mv 10.1080/21691401.2017.1313265
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1080_21691401_2017_1313265</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1999178875</sourcerecordid><originalsourceid>FETCH-LOGICAL-c441t-1b62233ba1fc8d7c4314a810036f763e4e429288c9e310fd4e992c1491e488ba3</originalsourceid><addsrcrecordid>eNp9kFtLwzAUx4Mobsx9BKXgo3TmJGmavCljXmDoi4JvIU0T19E1NemQfns7dnn0vJzD4X-BH0LXgGeABb4nwCUwDDOCIZ8BBUp4dobGu38KDL7OTzeGEZrGuMbDCOB5xi7RiAgqswz4GN296cZ31qwaX_vvPtFtW1dGd5VvEudD0uqqSbqVDbrtr9CF03W008OeoM-nxcf8JV2-P7_OH5epYQy6FApOCKWFBmdEmRtGgWkBGFPuck4ts4xIIoSRlgJ2JbNSEgNMgmVCFJpO0O0-tw3-Z2tjp9Z-G5qhUoGUEnIh8mxQZXuVCT7GYJ1qQ7XRoVeA1Y6SOlJSO0rqQGnw3RzSt8XGlifXkckgeNgLqmYgsNG_PtSl6nRf--CCbkwVFf2_4w9agHPc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1999178875</pqid></control><display><type>article</type><title>Nanotechnology application for pain therapy</title><source>Alma/SFX Local Collection</source><creator>Moradkhani, Mahmoud Reza ; Karimi, Arash ; Negahdari, Babak</creator><creatorcontrib>Moradkhani, Mahmoud Reza ; Karimi, Arash ; Negahdari, Babak</creatorcontrib><description>Prolonged delivery of analgesic drugs at target sites remains a critical issue for efficient pain management. The use of nano-carriers has been reported to facilitate applicable delivery of these agents to target sites with a reduced level of systemic toxicity. Different analgesics have been loaded onto various nano carriers, including those that are natural, synthetic and copolymer, for various medical applications. In this review, we will discuss the concept of nano-formulated carriers for analgesic drugs and their impacts on the field of pain management.</description><identifier>ISSN: 2169-1401</identifier><identifier>EISSN: 2169-141X</identifier><identifier>DOI: 10.1080/21691401.2017.1313265</identifier><identifier>PMID: 28395516</identifier><language>eng</language><publisher>England: Taylor &amp; Francis</publisher><subject>Analgesic drugs ; Analgesics ; Drug delivery ; Drug delivery systems ; nano-carriers ; Nanotechnology ; Pain ; Pain management ; Toxicity</subject><ispartof>Artificial cells, nanomedicine, and biotechnology, 2018-03, Vol.46 (2), p.368-373</ispartof><rights>2017 Informa UK Limited, trading as Taylor &amp; Francis Group 2017</rights><rights>2017 Informa UK Limited, trading as Taylor &amp; Francis Group</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c441t-1b62233ba1fc8d7c4314a810036f763e4e429288c9e310fd4e992c1491e488ba3</citedby><cites>FETCH-LOGICAL-c441t-1b62233ba1fc8d7c4314a810036f763e4e429288c9e310fd4e992c1491e488ba3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28395516$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Moradkhani, Mahmoud Reza</creatorcontrib><creatorcontrib>Karimi, Arash</creatorcontrib><creatorcontrib>Negahdari, Babak</creatorcontrib><title>Nanotechnology application for pain therapy</title><title>Artificial cells, nanomedicine, and biotechnology</title><addtitle>Artif Cells Nanomed Biotechnol</addtitle><description>Prolonged delivery of analgesic drugs at target sites remains a critical issue for efficient pain management. The use of nano-carriers has been reported to facilitate applicable delivery of these agents to target sites with a reduced level of systemic toxicity. Different analgesics have been loaded onto various nano carriers, including those that are natural, synthetic and copolymer, for various medical applications. In this review, we will discuss the concept of nano-formulated carriers for analgesic drugs and their impacts on the field of pain management.</description><subject>Analgesic drugs</subject><subject>Analgesics</subject><subject>Drug delivery</subject><subject>Drug delivery systems</subject><subject>nano-carriers</subject><subject>Nanotechnology</subject><subject>Pain</subject><subject>Pain management</subject><subject>Toxicity</subject><issn>2169-1401</issn><issn>2169-141X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNp9kFtLwzAUx4Mobsx9BKXgo3TmJGmavCljXmDoi4JvIU0T19E1NemQfns7dnn0vJzD4X-BH0LXgGeABb4nwCUwDDOCIZ8BBUp4dobGu38KDL7OTzeGEZrGuMbDCOB5xi7RiAgqswz4GN296cZ31qwaX_vvPtFtW1dGd5VvEudD0uqqSbqVDbrtr9CF03W008OeoM-nxcf8JV2-P7_OH5epYQy6FApOCKWFBmdEmRtGgWkBGFPuck4ts4xIIoSRlgJ2JbNSEgNMgmVCFJpO0O0-tw3-Z2tjp9Z-G5qhUoGUEnIh8mxQZXuVCT7GYJ1qQ7XRoVeA1Y6SOlJSO0rqQGnw3RzSt8XGlifXkckgeNgLqmYgsNG_PtSl6nRf--CCbkwVFf2_4w9agHPc</recordid><startdate>201803</startdate><enddate>201803</enddate><creator>Moradkhani, Mahmoud Reza</creator><creator>Karimi, Arash</creator><creator>Negahdari, Babak</creator><general>Taylor &amp; Francis</general><general>Taylor &amp; Francis Ltd</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>201803</creationdate><title>Nanotechnology application for pain therapy</title><author>Moradkhani, Mahmoud Reza ; Karimi, Arash ; Negahdari, Babak</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c441t-1b62233ba1fc8d7c4314a810036f763e4e429288c9e310fd4e992c1491e488ba3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Analgesic drugs</topic><topic>Analgesics</topic><topic>Drug delivery</topic><topic>Drug delivery systems</topic><topic>nano-carriers</topic><topic>Nanotechnology</topic><topic>Pain</topic><topic>Pain management</topic><topic>Toxicity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Moradkhani, Mahmoud Reza</creatorcontrib><creatorcontrib>Karimi, Arash</creatorcontrib><creatorcontrib>Negahdari, Babak</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Artificial cells, nanomedicine, and biotechnology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Moradkhani, Mahmoud Reza</au><au>Karimi, Arash</au><au>Negahdari, Babak</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Nanotechnology application for pain therapy</atitle><jtitle>Artificial cells, nanomedicine, and biotechnology</jtitle><addtitle>Artif Cells Nanomed Biotechnol</addtitle><date>2018-03</date><risdate>2018</risdate><volume>46</volume><issue>2</issue><spage>368</spage><epage>373</epage><pages>368-373</pages><issn>2169-1401</issn><eissn>2169-141X</eissn><abstract>Prolonged delivery of analgesic drugs at target sites remains a critical issue for efficient pain management. The use of nano-carriers has been reported to facilitate applicable delivery of these agents to target sites with a reduced level of systemic toxicity. Different analgesics have been loaded onto various nano carriers, including those that are natural, synthetic and copolymer, for various medical applications. In this review, we will discuss the concept of nano-formulated carriers for analgesic drugs and their impacts on the field of pain management.</abstract><cop>England</cop><pub>Taylor &amp; Francis</pub><pmid>28395516</pmid><doi>10.1080/21691401.2017.1313265</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2169-1401
ispartof Artificial cells, nanomedicine, and biotechnology, 2018-03, Vol.46 (2), p.368-373
issn 2169-1401
2169-141X
language eng
recordid cdi_crossref_primary_10_1080_21691401_2017_1313265
source Alma/SFX Local Collection
subjects Analgesic drugs
Analgesics
Drug delivery
Drug delivery systems
nano-carriers
Nanotechnology
Pain
Pain management
Toxicity
title Nanotechnology application for pain therapy
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T19%3A39%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Nanotechnology%20application%20for%20pain%20therapy&rft.jtitle=Artificial%20cells,%20nanomedicine,%20and%20biotechnology&rft.au=Moradkhani,%20Mahmoud%20Reza&rft.date=2018-03&rft.volume=46&rft.issue=2&rft.spage=368&rft.epage=373&rft.pages=368-373&rft.issn=2169-1401&rft.eissn=2169-141X&rft_id=info:doi/10.1080/21691401.2017.1313265&rft_dat=%3Cproquest_cross%3E1999178875%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1999178875&rft_id=info:pmid/28395516&rfr_iscdi=true